In conjunction with the American Society of Retina Specialists, the Macula Society, the Retina Society and Club Jules Gonin
Friday, Oct. 11, & Saturday, Oct. 12, 2019
Moscone Center, San Francisco, CA
Mark S. Humayun, MD, PhD and Judy E. Kim, MD
Program Planning Group
Mark S. Humayun, MD, PhD; Judy E. Kim, MD; Mark W. Johnson, MD; and Srinivas R. Sadda, MD
The 2019 Retina Subspecialty Day aims to provide a comprehensive and focused medical and surgical retina update for the retina subspecialist, interested ophthalmologist, and ophthalmologist in training. The meeting focuses on up-to-date, clinically and scientifically relevant retina topics presented by an international group of respected retina specialists. The major educational goals are to highlight new clinical, medical, and surgical advances and investigative information and to transfer it to the participant so that it is useful in patient care. The meeting attains these goals by engaging the participant in didactic presentations, panel discussions, audience response polling, and audience response question generation for moderated panels.
The intended target audience for this program is vitreoretinal specialists, members in fellowship training, and general ophthalmologists who are engaged in the diagnosis and treatment of vitreoretinal diseases.
The goals of this program are to:
- Provide attendees with a comprehensive, state-of-the-art update on the diagnosis and management of vitreoretinal diseases
- Provide insight into new and upcoming diagnostic and therapeutic options for the medical and surgical evaluation and treatment of a variety of disorders
Upon completion of this activity, participants should be able to:
- Present established and innovative approaches to the medical and surgical management of vitreoretinal diseases and disorders
- Identify imaging tests that are most helpful in the diagnosis and management of retinal conditions and discuss emerging developments in retinal imaging
- Describe new vitreoretinal surgical techniques and instrumentation
- Identify new developments in the understanding of hereditary retinal degenerations, retinal vascular disease, AMD and other macular diseases, pediatric retinal diseases, uveitis, and ocular oncology
- Summarize current and new clinical trial data for retinal diseases such as AMD, diabetic retinopathy, hereditary retinal conditions, and retinal vein occlusion
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses and guests are not eligible for CME credits.
Find more information about CME.